According to Genprex's latest financial reports the company has $6.73 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $20.95 M | -45.76% |
2021-12-31 | $38.62 M | 41.4% |
2020-12-31 | $27.31 M | 1264.28% |
2019-12-31 | $2 M | -76.72% |
2018-12-31 | $8.6 M | 5233.87% |
2017-12-31 | $0.16 M | -89.94% |
2016-12-31 | $1.6 M | 584.1% |
2015-12-31 | $0.23 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 2,989.91% | ๐บ๐ธ USA |